Structural Heart Occlusion Devices Market Report 2025: Segments, Share, Regulatory, Reimbursement, Interventions and Forecasts 2015-2036

The Structural Heart Occlusion Devices market presents opportunities in offering minimally invasive solutions for congenital heart defects, enhancing recovery. Insights on market trends, competitive ...
Seeking Alpha

Boston Scientific WATCHMAN FLX™ Left Atrial Appendage Closure Device Demonstrates Superior Bleeding Risk Reduction to Oral Anticoagulation Following a Cardiac Ablation in the ...

Data also demonstrates that the stroke risk reduction device is as effective as oral anticoagulants for patients with atrial fibrillation following a cardiac ablation The trial met the primary safety ...
abc27

WellSpan Health – The Watchman Device Gives Cardiac Patients New Found Hope

A device smaller than a quarter is giving heart patients a new lease on life. The Watchman device is implanted in the heart to prevent blood clots from forming without the need of blood thinners. This ...
NJBIZ

J&J MedTech buys cardiac device company for $400M

Johnson & Johnson MedTech has strengthened its cardiac treatment offerings with the $400 million acquisition of Laminar Inc., a private medical device company headquartered in Santa Rosa, Calif. The ...
Nasdaq

Abbott Strengthens Left Atrial Appendage Closure Leadership With U.S. Availability of Amplatzer™ Steerable Delivery Sheath for the Company's Amulet™ Device

First and only steerable delivery system designed to help seal the left atrial appendage (LAA) in people with atrial fibrillation who are at an increased risk of stroke Now available in the U.S., ...